Pharmaceutical patents remains a controversial issue in the Spanish market, due to previous case law prohibiting product patentability up until October 1992. In 2009 some landmark appeals finally reached the Supreme Court. The court's rulings will affect many patents and products; the industry is on tenterhooks waiting to discover what will be decided.
The main draw at Clifford Chance is the “highly respected” Miquel Montañá, who has stellar international credentials; he usually represents research-based firms. Amat y Vidal Quadras name partner Miguel Vidal-Quadras receives high praise as “a pioneer in the generic industry” with “sparkling courtroom presence”. Sources say “he is without doubt one of the best”.
Luis Fernánde-Novoa is the leading light at Howrey and wins plaudits for his wide pharmaceutical experience. Sources have “an excellent impression” of Grau & Angulo’s Javier Huarte, who is making great strides in the field. Clients include Teva, Sandoz, Ratiopharm and Mylan. Bird & Bird’s Manuel Lobato’s growing experience in the pharmaceutical area attracts consistent praise from interviewees, who describe him as a “strategic-minded litigator with good knowledge of the field”; he also benefits from “a strong support team”. José Massaguer maintains a broad practice at Uría Menéndez and is “a well-recognised, skilful litigator”.
The “impressive and effective” Isabel Carulla is a senior associate at Clifford Chance. At the same firm, Montserrat Lopez-Bellosta is noted for her “strong work ethic and sound arguments”. Second in command to José Massaguer at Uría Menéndez is the highly respected senior associate Ingrid Pi.